Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias
FILTRAR POR:
380 ARTÍCULOS , VIENDO DEL 316 AL 330
Panza F, Seripa D, Lozupone M, Solfrizzi V, Imbimbo BP, Barulli MR, Tortelli R, Capozzo R, Bisceglia P, Dimitri A, Stallone R, Dibello V, Quaranta N, Daniele A, Bellomo A, Greco A, Logroscino G.
Expert Opin Biol Ther. 2018 Jan;18(1):25-35. doi: 10.1080/14712598.2018.1389885. Epub 2017 Oct 16.
How efficient are rodent models for Alzheimer's disease drug discovery?
Guo B, Zhou Q.
Expert Opin Drug Discov. 2018 Feb;13(2):113-115. doi: 10.1080/17460441.2018.1398730. Epub 2017 Oct 31.
The physical approximation of APP and BACE-1: A key event in alzheimer's disease pathogenesis
Sun J, Roy S.
Dev Neurobiol. 2018 Mar;78(3):340-347. doi: 10.1002/dneu.22556. Epub 2017 Nov 13.
A very low dose of rivastigmine-induced Pisa syndrome in a clozapine-treated patient
Chao PC, Li JC, Yeh TC, Yeh CB.
Aust N Z J Psychiatry. 2018 Feb;52(2):204-205. doi: 10.1177/0004867417741983. Epub 2017 Nov 9.
Connecting Alzheimer's disease to diabetes: Underlying mechanisms and potential therapeutic targets
Vieira MNN, Lima-Filho RAS, De Felice FG.
Neuropharmacology. 2018 Jul 1;136(Pt B):160-171. doi: 10.1016/j.neuropharm.2017.11.014. Epub 2017 Nov 10.
Tricco AC, Ashoor HM, Soobiah C, Rios P, Veroniki AA, Hamid JS, Ivory JD, Khan PA, Yazdi F, Ghassemi M, Blondal E, Ho JM, Ng CH, Hemmelgarn B, Majumdar SR, Perrier L, Straus SE.
J Am Geriatr Soc. 2018 Jan;66(1):170-178. doi: 10.1111/jgs.15069. Epub 2017 Sep 29.
Insulin-Degrading Enzyme in the Fight against Alzheimer's Disease
Kurochkin IV, Guarnera E, Berezovsky IN.
Trends Pharmacol Sci. 2018 Jan;39(1):49-58. doi: 10.1016/j.tips.2017.10.008. Epub 2017 Nov 10.
Bortoli PM, Alves C, Costa E, Vanin AP, Sofiatti JR, Siqueira DP, Dallago RM, Treichel H, Vargas GDLP, Kaizer RR.
J Inorg Biochem. 2018 Apr;181:104-110. doi: 10.1016/j.jinorgbio.2017.11.001. Epub 2017 Nov 7.
Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link
Zhang Y, Huang NQ, Yan F, Jin H, Zhou SY, Shi JS, Jin F.
Behav Brain Res. 2018 Feb 26;339:57-65. doi: 10.1016/j.bbr.2017.11.015. Epub 2017 Nov 21.
Renn BN, Asghar-Ali AA, Thielke S, Catic A, Martini SR, Mitchell BG, Kunik ME.
Am J Geriatr Psychiatry. 2018 Feb;26(2):134-147. doi: 10.1016/j.jagp.2017.09.027. Epub 2017 Oct 10.
Microglia-Mediated Neuroprotection, TREM2, and Alzheimer's Disease: Evidence From Optical Imaging
Condello C, Yuan P, Grutzendler J.
Biol Psychiatry. 2018 Feb 15;83(4):377-387. doi: 10.1016/j.biopsych.2017.10.007. Epub 2017 Oct 14.
Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease
Seo EJ, Fischer N, Efferth T.
Pharmacol Res. 2018 Mar;129:262-273. doi: 10.1016/j.phrs.2017.11.030. Epub 2017 Nov 24.
Intranasal insulin in Alzheimer's disease: Food for thought
Chapman CD, Schiöth HB, Grillo CA, Benedict C.
Neuropharmacology. 2018 Jul 1;136(Pt B):196-201. doi: 10.1016/j.neuropharm.2017.11.037. Epub 2017 Nov 24.
Multimedia Aided Consent for Alzheimer's Disease Research
Palmer BW, Harmell AL, Dunn LB, Kim SY, Pinto LL, Golshan S, Jeste DV.
Clin Gerontol. 2018 Jan-Feb;41(1):20-32. doi: 10.1080/07317115.2017.1373177. Epub 2017 Nov 28.
Camargo LC, Campos GAA, Galante P, Biolchi AM, Gonçalves JC, Lopes KS, Mortari MR.
Neuropeptides. 2018 Feb;67:79-86. doi: 10.1016/j.npep.2017.11.010. Epub 2017 Nov 28.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.